These observations are consistent with the evidence that honokiol inhibits the growth of cancer cells by targeting EGFR and its downstream molecular targets and suggest that these mechanism are in play in HNSCC. The gene discussed is EGFR; the disease is head and neck squamous cell carcinoma.